SPONSOR
Shenzhen Ionova Life Sciences Co., Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Breast Cancer (Locally Advanced or Metastatic)Advanced Solid CancersMetastatic (Stage IV) Breast CancerOvarian CancerEndometrial CancerCancerSolid Tumor, AdultCancer MetastaticSolid CarcinomaSolid Tumor, Unspecified, Adult
Shenzhen Ionova Life Sciences Co., Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer, Ovarian Cancer.
The trial portfolio spans Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shenzhen Ionova Life Sciences Co., Ltd.
How many clinical trials has Shenzhen Ionova Life Sciences Co., Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shenzhen Ionova Life Sciences Co., Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shenzhen Ionova Life Sciences Co., Ltd. research focus on?
Shenzhen Ionova Life Sciences Co., Ltd. clinical trials span Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer, Ovarian Cancer, Endometrial Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shenzhen Ionova Life Sciences Co., Ltd. clinical trial?
To participate in a Shenzhen Ionova Life Sciences Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shenzhen Ionova Life Sciences Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shenzhen Ionova Life Sciences Co., Ltd.
NCT07612891 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
Breast Cancer (Locally Advanced or Metastatic)
NCT04443088 Phase 1
Recruiting
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology